The cluster is dominated by liquidity-driven sales (option exercises + tax withholding) from C-suite executives, with a single director's $1.38M open-market sale being the only notable cash transaction. The $25K director buy is negligible. Monitor the next 8-K or earnings release for any operational updates that might explain the director's sale, but the overall pattern suggests routine portfolio management rather than a bearish signal.
PGEN drugs
PGEN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 31 $6.93entry
- T+1 · 3mo ago −1.01%α −0.32% · $6.86
- T+5 · 2mo ago +0.79%α +0.94% · $6.99
- T+20 · 7w ago +14.57%α +14.51% · $7.94
- T+54 · todayOpen
- T+60 · in 7d Pending
Price Chart
How similar events traded
Executive Summary
A mixed insider cluster at Precigen shows a director selling $1.38M in open-market shares and the CCO selling $594K post-exercise, while a director bought $25K. The total open-market sales of $2.11M represent ~0.08% of the $2.6B market cap, falling below the 0.1% materiality threshold. The sales cluster around option exercises and tax withholding, suggesting liquidity-driven rather than informational selling, consistent with the weak predictive power of insider sales per academic literature.
Key Financial Metrics
Key Facts
- Director Jeffrey B. Kindler sold 185,000 shares at $7.44 for $1.38M on 2026-08-26.
- CCO Phil Tennant sold 79,166 shares at $7.50 for $594K on 2026-08-25, following option exercises.
- Director Nancy H. Agee bought 3,400 shares at $7.23 for $25K on 2026-08-21.
- Total open-market sales of $2.11M represent ~0.08% of $2.6B market cap, below the 0.1% materiality threshold.
- Multiple C-suite executives (CEO, CFO, COO, CLO) exercised options and surrendered shares for tax withholding on 2026-08-23, indicating routine vesting events.
Financial Impact
Open-market sales of $2.11M (0.08% of market cap) are trivial relative to company size.
Risk Factors
- Director Kindler's $1.38M sale could indicate personal portfolio rebalancing or a negative view not shared by other insiders.
- C-suite option exercises and tax withholding are routine and carry no informational content.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PGEN-1787963994204 |
Track record
13 reports on PGEN
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +52.17% at T+60 after the May 13, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $4.22 to $4.66 Now $4.30 +1.90% ▲ +10.43% +7.14% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 3/10 Viewing Entry $6.93 to $6.99 Now $4.30 −37.95% ▲ +0.79% +0.94% vs SPY
- Aug 26, 202611w ago 144 Neutral 3/10 Entry $7.19 to $7.14 Now $4.30 −40.19% ▼ −0.70% −0.96% vs SPY
- Aug 25, 202611w ago Insider Cluster Bearish 4/10 Entry $7.42 to $7.01 Now $4.30 +42.05% ▲ +5.53% +5.41% vs SPY
- Aug 25, 202611w ago Insider Cluster Neutral 2/10 Entry $7.42 to $7.01 Now $4.30 −42.05% ▼ −5.53% −5.41% vs SPY
- Aug 7, 202614w ago Insider Cluster Neutral 2/10 Entry $7.00 to $6.55 Now $4.30 −38.57% ▼ −6.43% −6.38% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $6.53 to $6.86 Now $4.30 −34.15% ▲ +5.05% +5.15% vs SPY
- Jul 1, 202619w ago Insider Cluster Bearish 5/10 Entry $5.64 to $5.53 Now $4.30 +23.76% ▲ +1.95% +2.88% vs SPY
- Jun 24, 202620w ago 8-K Neutral 3/10 Entry $5.52 to $5.25 Now $4.30 −22.10% ▼ −4.89% −6.45% vs SPY
- Jun 1, 202624w ago Insider Cluster Neutral 3/10 Entry $3.86 to $3.71 Now $4.30 +11.40% ▼ −3.89% −0.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers